Co-Diagnostics Inc. CODX on Wednesday said it completed clinical and analytical performance studies for the Co-Dx PCR Flu A/B ...
Co-Diagnostics, Inc.(Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented ...
Credit: Getty Images. RSV primarily affects children and older adults, and can lead to severe illness or death. Respiratory syncytial virus (RSV) affects infants, young children, and older adults, ...
Respiratory syncytial virus cases are rising all over the country as the fall and winter months settle in, but the Southeast is experiencing the brunt of the spike, signaling a return to pre-pandemic ...
This past winter, hospitals and clinics across Indiana filled up with patients suffering from different respiratory illnesses that have much the same symptoms: COVID-19, flu and RSV. And many more ...
Respiratory syncytial virus (RSV) can cause substantial morbidity and mortality among older adults. An mRNA-based RSV vaccine, mRNA-1345, encoding the stabilized RSV prefusion F glycoprotein, is under ...
Please provide your email address to receive an email when new articles are posted on . Only one infant with respiratory syncytial virus (RSV) lower respiratory tract disease (LRTD) in the nirsevimab ...
The study included 31,900 infants, 49.1% of whom received nirsevimab. HealthDay News — Nirsevimab is effective for protecting infants against respiratory syncytial virus (RSV)-associated lower ...
H1N1, influenza A and RSV infections, with doctors attributing the surge partly to delayed monsoon conditions and warning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results